Indivior Pharmaceuticals Inc
INDV
Rank in Stocks
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Share Price
$34.01
Last synced: 2026-10-19
Market Cap
$4.24B
Change (1 day)
4.81%
Change (1 year)
40.02%
Country
US
Trade Indivior Pharmaceuticals Inc (INDV)
Category
Healthcare
Number of shares outstanding for Indivior Pharmaceuticals Inc (INDV)
Number of shares outstanding as of June 2026: 125.35M
According to Indivior Pharmaceuticals Inc latest financial reports and stock price the company's current number of shares outstanding is 125.35M. At the end of December 2023 the company had 137.31M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Indivior Pharmaceuticals Inc (INDV) from 2016 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 125.35M | -5.04% |
| 2024 | 132.00M | -3.86% |
| 2023 | 137.31M | -1.23% |
| 2022 | 139.01M | -4.56% |
| 2021 | 145.66M | -0.62% |
| 2020 | 146.57M | 0.36% |
| 2019 | 146.05M | 0.42% |
| 2018 | 145.43M | 0.84% |
| 2017 | 144.23M | 0.17% |
| 2016 | 143.97M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,814.08% |
IN
|
